BREAKINGVIEWS

VW’s CEO soap opera is darker than Tesla’s

7 Dec 2021READY SOON

Herbert Diess is likely to stay as the German carmaker’s boss but with wings clipped after a clash with unions. His ambitious battery plans make Volkswagen a more credible rival to Elon Musk’s firm. Unlike the Tesla founder’s antics, its leadership dramas reflect deep challenges.

Aramco pipeline is net win for BlackRock and Saudi

7 Dec 2021READY SOON

The oil giant is raising $15.5 bln by selling 49% of the cash flow from its gas pipes to the fund giant and partners. Backing from blue-chip investors helps Riyadh unlock international finance. For BlackRock, a 10%-plus return compensates for supporting a major carbon emitter.

China property debt crisis puts founders on spot

7 Dec 2021

Investors are pushing troubled developer Kaisa to avoid default and follow rival Agile’s lead by selling bonds that convert into equity. That, and other options on the table, present founder-executives with a hard choice: cede prized majority control, or risk insolvency.

Take China’s easing signals with a grain of salt

7 Dec 2021

Beijing is flagging a fresh focus on economic stability as growth slows, dropping tough talk about tech monopolies while pumping $188 bln into banks. Some battered sectors will get political breathing room, but this probably isn’t the sort of stimulus investors are looking for.

Zegna tailors elegant fix for BuzzFeed problem

6 Dec 2021

The Italian suit-maker and the millennial media group are both going public through SPACs. But Zegna has raised extra funds that kick in if investors extract money before the deal closes, as 96% of BuzzFeed’s did. With cash comes confidence; Buzzfeed ended up with less of both.

Boots exit may smooth way for Walgreens buyout

6 Dec 2021

The $40 bln drugstore operator may sell its UK chain, less than a decade after buying it. A sale could raise $8 bln for the U.S. group to beef up its own in-store clinics. And if Chairman Stefano Pessina wants one last big deal, a leaner Walgreens would be an easier target.

Saint-Gobain’s U.S. deal will cement its Sika envy

6 Dec 2021

The $34 bln French construction firm tried and failed to buy its Swiss rival, which then went on a growth spurt. Saint-Gobain’s $2.3 bln offer for U.S. group GCP will help it decarbonise. The catch is that Sika made a similar move last month, and the returns on that look better.

UK health robot SPAC is punt on big pharma buyout

6 Dec 2021

The Zaoui brothers are merging their blank-cheque firm with BenevolentAI, which uses tech to discover new drugs. A $440 mln cash infusion will keep computers whirring, but revenue remains distant. Investors including AstraZeneca and Sanofi’s former CEO hint at a future takeover.

Alibaba’s new CFO signals shifting priorities

6 Dec 2021

The Chinese e-commerce company, whose market value has halved to $300 bln this year, is replacing finance chief Maggie Wu. During her seven-year tenure, Alibaba successfully courted foreign investors. Successor Toby Xu’s experience suggests there will be a greater focus at home.

China property market faces more nationalisation

6 Dec 2021

Evergrande, the country’s most indebted developer, has admitted it might formally default. With $10 bln in property bonds maturing in January alone, officials are under pressure to keep the sector from collapsing. The most expedient solution is to put more housing in state hands.

DocuSign shows risk of investing along dotted line

3 Dec 2021

A slowdown in demand ripped $18 bln off the digital document-signing firm’s market value. The company’s response – spending more to revive sales – adds to the near-term pain. For profitless companies reliant on ambitious forecasts, sharp corrections are a signature move.

Nordic drug buyout flop highlights hidden gem

3 Dec 2021

The $8 bln takeover of Swedish Orphan Biovitrum failed after buyers could not secure 90% of the shares. The market reaction suggests the deal is dead. But investor AstraZeneca’s role in the failed bid and its interest in a respiratory disease treatment provides some comfort.

Transatlantic food delivery value gap will narrow

3 Dec 2021

DoorDash and Just Eat Takeaway have similar revenue and growth prospects, but the $57 bln U.S. firm is worth four times as much as its Dutch rival. Better profitability and an earlier move into groceries helps explain the gap. DoorDash’s push into Europe suggests it won’t last.